A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL

Clinical trial NCT02423291 · COMPLETED

Trial details

NCT number: NCT02423291
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Mediastinal Large B Cell Lymphoma

Start date: 2013-10-01
Primary completion: 2016-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.